Centre bans 16 fixed-dose drug combinations, citing public health concerns
The Indian government has banned 16 fixed-dose combination (FDC) drugs, citing a lack of therapeutic justification and potential health risks. This decision follows a review by the Drugs Technical Advisory Board to ensure the availability of scientifically validated medicines.
Why it matters
Regulatory actions against irrational drug combinations are essential for protecting public health and ensuring the efficacy of pharmaceutical treatments.
The Centre has prohibited the manufacture, sale and distribution of 16 fixed-dose combination (FDC) drugs, saying they lack "therapeutic justification" and their continued use was not considered beneficial in relation to the potential risks involved.
The report is a factual summary of a government health policy decision.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in